HCW Biologics News - October 9, 2026
HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic?
Shares of HCW Biologics surged 13% to $1.73 after the company disclosed that the FDA provided formal guidance on how to advance its lead cancer drug candidate...
🟢 HCW Biologics is trading 13% up today after FDA guidance on cancer-study IND next steps
HCW Biologics is trading at $1.73 (+12.95%) after a recent FDA Type B meeting provided guidance on next steps for a first-in-human solid-tumor study. - The...
🟢 HCW Biologics is trading 6.5% up today after FDA guidance clarified IND next steps
HCW Biologics is trading at $1.63, up +6.54%, after FDA Type B meeting guidance clarified next steps for its planned first-in-human solid-tumor study of...